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Functional Characterization of the Epidermal
Cholinergic System In Vitro
Hjalmar Kurzen1, Carmen Henrich1, Dirk Booken1, Nina Poenitz1, Alexei Gratchev1, Claus-Detlev Klemke1,
Monika Engstner2, Sergij Goerdt1 and Nicole Maas-Szabowski3
The aim of this study was to analyze the influence of cholinergic and anticholinergic drugs on epidermal
physiology using organotypic cocultures (OTCs). Blocking of all acetylcholine receptors (AChRs) by combined
treatment with mecamylamine and atropine or treatment with strychnine (blocking a9nAChR) for 7–14 days
resulted in a complete inhibition of epidermal differentiation and proliferation. Blockage of nicotinic (n)AChR
with mecamylamine led to a less pronounced delay in epidermal differentiation and proliferation than blockage
of muscarinic (m)AChR with atropine, evidenced by reduced epithelial thickness and expression of terminal
differentiation markers like cytokeratin 2e or filaggrin. In OTCs treated with atropine, mecamylamine, or
strychnine, we could demonstrate intracellular lipid accumulation in the lower epidermal layers, indicating a
severely disturbed epidermal barrier. In addition, we observed prominent acantholysis in the basal and lower
suprabasal layers in mecamylamine-, atropine-, and strychnine-treated cultures, accompanied by a decreased
expression of cell adhesion proteins. This globally reduced cell adhesion led to cell death via intrinsic activation
of apoptosis. In contrast, stimulation of nAChR and mAChR with cholinergic drugs resulted in a significantly
thickened epithelium, accompanied by an improved epithelial maturation. In summary, we show that epidermal
AChR are crucially involved in the regulation of epidermal homeostasis.
Journal of Investigative Dermatology (2006) 126, 2458–2472. doi:10.1038/sj.jid.5700443; published online 29 June 2006
INTRODUCTION
The epidermis is a highly specialized stratified epithelium
that functions to protect the body from physical and chemical
damage, infection, dehydration, and heat loss. To achieve
this goal, a protective, semipermeable barrier is formed, the
stratum corneum. To maintain this critical barrier, the
epidermis undergoes constant renewal and repair. Keratino-
cytes undergo a program of terminal differentiation expres-
sing a set of structural proteins, keratins, that assemble into
filaments and function to maintain cell and tissue integrity.
Two types of cell adhesion structures, desmosomes and
hemidesmosomes, function to connect the keratin cytoskele-
ton to the cell surface. In concert with adherens junctions and
tight junctions that are connected to the actin filaments, they
mediate epidermal cell adhesion and regulate the tightness of
the epidermal barrier. Epidermal differentiation, cell adhe-
sion, and barrier formation can be influenced by various
factors such as calcium ions, vitamin A or D, growth
hormones, or cytokines (Fuchs, 1990; Anderson and van
Itallie, 1995; Presland and Jurevic, 2002; Segre, 2003). A
recently recognized player in the orchestra of epidermal
physiology is the extraneuronal cholinergic system. It has
been shown to influence various cell functions of resident
skin cells such as terminal differentiation and barrier
formation, sweat and sebum secretion, as well as micro-
circulation. It is firmly established that human keratinocytes
as well as endothelial cells synthesize and degrade acet-
ylcholine (ACh) that acts via the muscarinic (mAChRs) and
nicotinic receptors (nAChRs) either autocrine or paracrine on
the surrounding cells like fibroblasts or melanocytes (Smith
et al., 1992; Grando, 1997; Kirkpatrick et al., 2003; Kurzen
and Schallreuter, 2004). Hitherto, five molecular subtypes of
mAChRs have been identified in keratinocytes, melanocytes,
and fibroblasts. These receptors are single-subunit transmem-
brane glycoproteins. The M2 and M4 receptors are coupled to
G-proteins of the Gi family leading to inhibition of cAMP
synthesis via adenylyl cyclase. The M1, M3, and M5 subtypes
are coupled to the Gq class of the G-proteins acting on
downstream signals such as phospholipase C or D, conse-
quently regulating intracellular calcium levels. The mAChRs
have been mapped to different layers of the epidermis.
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However, the exact functional roles of the muscarinic
receptors need yet to be demonstrated (Grando et al.,
1995b; Ndoye et al., 1998; Buchli et al., 2001; van Koppen
and Kaiser, 2003; Kurzen et al., 2004). Human nAChRs are
composed of different subunits, that is, a1–a10, b1–b4, g, d,
and e, which can be combined to pharmacologically distinct
pentameric ion channels. The a1, b1, and d chains form
heteropentamers present at the neuromuscular junction
together with the g (fetal phenotype) and e (adult phenotype)
chains. The neuronal heteropentamers that contain the
a3 subunit together with other subunits are also termed
a3*-nAChR. The a7 and a9 subunits form homopentamers and
are mainly gating calcium, whereas the a3*-nAChR is
permeable to both sodium and potassium (Seguela et al.,
1993; Millar, 2003). It has been suggested that a9 subunits
may form heteromeric nAChR together with a10 subunits
(Elgoyhen et al., 1994; Sgard et al., 2001). Depending on their
subunit composition, the nAChR show different affinities to
ACh, choline, and other cholinergic compounds like nicotine.
Although a2-, a4-, a6-, and b3-nAChR have never been
demonstrated in human skin, several studies have identified
the presence of a3-, a5-, a7-, a9-, a10-, b2-, and b4-nAChR. In
addition, the presence of b1-nAChR mRNA and protein was
shown only recently (Grando et al., 1995b; Nguyen et al.,
2001; Arredondo et al., 2002; Kurzen et al., 2004).
Pharmacological stimulation of the a3*-nAChR has been
shown to enhance cell aggregation, cell contact formation,
and lateral cell migration (Grando et al., 1995a). A central,
calcium-dependent role in terminal differentiation and
apoptosis has been suggested for the a7-nAChR, based on
cell culture experiments of keratinocyte monolayers. In
addition, a7-nAChR knockout mice have a highly prolifera-
tive, thickened epidermis with delayed terminal differentia-
tion (Arredondo et al., 2002). However, also other nAChR
seem to be involved in the regulation of epidermal barrier
formation as indicated by the pharmacological profile
reported to enhance a process named ‘‘apoptotic’’ secretion.
A combination of antimuscarinergic and nicotinergic com-
pounds was shown to be required, suggesting a regulatory
role also for mAChR or for the a3*- and a9-nAChR (Nguyen
et al., 2001).
The role of AChR in the regulation of epidermal cell
adhesion has been a controversial issue especially as regards
to the role of the cholinergic system in the pathogenesis of the
autoimmune blistering skin disease pemphigus vulgaris
(Nguyen et al., 1998; Grando et al., 2001; Stanley et al.,
2001). In contrast to the current dogma favoring an exclusive
role of the desmosomal cadherin desmoglein 3 (Dsg3) in the
pathogenesis of pemphigus vulgaris (Amagai et al., 1991;
Schmidt et al., 2000; Hertl and Veldman, 2001; Amagai,
2003), there have been several reports on the presence of
autoantibodies against cholinergic receptors in the serum of
up to 85% of these patients (Nguyen et al., 2000a). In
addition, both the desmosomal and classical cadherins can
be upregulated by cholinergic substances like carbachol,
whereas their phosphorylation has been shown to be
promoted by pemphigus vulgaris IgG. This finding has
prompted clinical trials reporting a beneficial effect of
nicotine or ACh-esterase inhibitors on the clinical course of
pemphigus vulgaris. Another central point in this line of
evidence was the observation that, on the one hand atropine
and mecamylamine, inhibitors of AChR, can induce acantho-
lysis in vitro and that, on the other hand, nicotine and
muscarine are able to reverse acantholysis induced by
pemphigus serum on keratinocyte monolayer cultures.
However, the exact mechanism of the observed effects has
never been clarified nor have the AChR involved in
keratinocyte adhesion been pinned down convincingly.
One recent study suggested a central role for the a3*-, a9-,
and M3 AChR in this process (Nguyen et al., 2000b, 2004a, b;
Grando, 2004).
The goal of this study was to examine the influence of
common cholinergic compounds that are partly in clinical
use, on epidermal physiology. In an attempt to approach the
physiological situation in human skin and in contrast to
previous experiments using keratinocyte monolayers, we
used organotypically cultured primary keratinocytes as a
three-dimensional epidermis model. We provide functional
evidence for a crucial role of several epidermal AChR sub-
types in the regulation of epidermal barrier formation, terminal
differentiation epidermal cell adhesion, and apoptosis.
RESULTS
Control OTC correspond to normal epidermis with respect to
morphology and AChR expression
On the day of the organotypic coculture (OTC) airlift,
keratinocytes had grown for 2 days submerged on the
fibroblast containing collagen gel. On histological examina-
tion, a two- to three-layered non-keratinizing epithelium is
formed. After 5 days in culture, the first signs of differentiation
became visible with the upper layers flattening and markers
of terminal differentiation like cytokeratin (CK)1/10 and Ck2e
becoming positive. After 7 days, these markers became more
prominent and a stratum corneum became detectable. At the
same time, basement membrane components are formed and
the epithelium becomes firmly anchored on the collagen
gel. After 12–14 days, the epidermis is multilayered and
the stratum granulosum and corneum are fully developed
(Figure 1a).
As a prerequisite for the possible action of cholinergic
compounds, we examined the expression of AChR in OTC by
immunofluorescence (IF) and compared their expression with
normal epidermis. In mature untreated control OTC, we
found all AChR examined (a3, a7, a9, m1, m3, and m5) in an
epidermis-like pattern (Figure 2a–e). Performing quantitative
real-time reverse transcription (RT)-PCR analysis, we exam-
ined the quantity of a a9nAChR mRNA (relative to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA)
in OTCs at different time points. In relation to normal human
skin, on day 0 a9nAChR mRNA was found increased 2-fold,
77-fold on day 5, and 166-fold on day 10 (not shown).
Cholinergic antagonists severely interfere with keratinocyte
adhesion and differentiation
We first wanted to know whether AChR are needed for the
development of a normal epithelium. We therefore blocked
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Figure 1. OTC morphology. HE staining of untreated organotypic cocultures (a) (control OTC), (b) OTC treated with nicotine (nicOTC), (c) muscarine
(muscOTC), (d) carbachol (carbaOTC) (e) mecamylamine and atropine (mec/atropOTC), (f) strychnine (stryOTC), (g) a-bungarotoxin (bgtxOTC)
(h) glycopyrrolate (gpbOTC), (i) mecamylamine (mecOTC), and (j) atropine (atropOTC). All substances were used in 1 mM concentrations over 10 days
after air-lifting. Note that stimulation of (b–d) AChR leads to a significantly increased thickness of the obtained epithelium. (e) Inhibition of all AChR by
combined treatment with atropine and mecamylamine completely inhibits formation of a multilayered epithelium. (f) Inhibition of a9-nAChR by strychnine
significantly inhibits epidermal maturation and causes acantholysis. Inhibition of nAChR by (i) mecamylamine or predominant inhibition of mAChR by
(j) atropine causes acantholysis in the lower epidermal layers (arrows). a-Bungarotoxin promotes epidermal differentiation without increase in epidermal
thickness; (i) there is a prominent granular layer. (h) Glycopyrrolate interferes with the maturation of the epidermal barrier in the upper epidermal layers.
Note the disturbed architecture suggesting a desynchronization of the differentiation process. Bar¼ 100mm.
a b c d e
Figure 2. Differentiation-specific AChR subunit expression in control OTCs. Untreated OTCs cultured for 12 days. (a) IF analysis reveals presence of a3nAChR
in the basal layers, (b) whereas a7nAChR can be detected in the upper spinous and granular layers. (c) Like in the epidermis, a9nAChR are present in the
basal in lower suprabasal layers. (d) M3 and (e) M5 immunoreactivity is detectable mainly in the basal cells. Bar¼ 100mm.
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all AChR by culturing the OTC in the presence of mM
concentrations of mecamylamine and atropine (mec/atrop-
OTC). In doing so, a functional multilayered epithelium did
not develop in our system (Figure 1). In order to exclude toxic
and unspecific effects, we determined the concentration of
lactate dehydrogenase (LDH) in the OTC supernatant.
Compared to control cultures, no significantly increased
LDH concentration could be observed in the supernatant.
In the next step, we applied anticholinergic substances
with different AChR subtype selectivity and compared the
obtained effects. Using mecamylamine (mecOTC), atropine
(atropOTC), and strychnine (stryOTC), we obtained func-
tional epithelia, albeit with significantly altered properties as
compared to control: there was a prominent acantholysis in
the lower suprabasal layers and a significantly delayed
epidermal differentiation and with the exception of meca-
mylamine also a significant reduction of the epidermal
thickness. Similar changes could not be observed after OTC
culture in the presence of a-bungarotoxin (a-bgtxOTC),
hexamethonium (hexaOTC), d-tubocurarine (curOTC), or
glycopyrrolate (gpbOTC). However, comparing relative
epithelial thickness, atropOTC, stryOTC, bgtxOTC, and
gpbOTC were significantly thinner than control, whereas
mecOTC, hexaOTC, and curOTC did not show any
significant change in thickness (Figure 3). In addition,
bgtxOTC showed a marked hypergranulosis and gpbOTC
displayed a disturbed architecture in the suprabasal cell
layers, indicating a desynchronization of the stratification and
differentiation process (Figure 1). Again, no increase of LDH
in the culture medium could be demonstrated except for
strychnine, where we observed a slightly elevated LDH
concentration at 1 mM (not shown).
OTC thickness is increased by cholinergic agonists
We wanted to find out whether stimulation of all the AChR,
the nAChR, or the mAChR would lead to different effects on
epidermal thickness. In nicOTC, we found the most
significant increase in epithelial thickness as compared to
control OTC, whereas muscOTC and carbOTC showed only
a slight, but significant increase (Figure 3). Cytotoxic effects
were not observed using the LDH release assay.
Expression of markers of terminal differentiation in OTC
In order to characterize the degree of maturation of the
different OTCs, we used antibodies against CKs. In fully
developed control OTC, all markers of terminal differentia-
tion applied (CK2e, CK5, CK10, and filaggrin) corresponded
to normal epidermis, except the activation marker CK6,
which remained positive at all times. Ck2e and filaggrin were
coexpressed in the granular and uppermost spinous layers
indicating maturation and cornification of the epithelium
(Figure 4). On day 5, control OTC, nicOTC, muscOTC, and
carbOTC only showed a weak CK2e and filaggrin staining
which became considerably more intense and extended after
7 days. In contrast to the agonist-treated OTC, in the
mecOTC, atropOTC, and stryOTC, CK2e remained comple-
tely negative at all times. In the same specimens, filaggrin
showed a weak cytoplasmic staining in the cells of the
granular layer. A weak CK10 expression could be detected in
mecOTC and atropOTC, whereas in stryOTC CK10 could not
be detected. CK6 staining intensity was most pronounced in
atropOTC, whereas in all other OTC the staining was
comparable to control OTC. A weak CK19 staining could
be detected in stryOTC and single cells of atropOTC, whereas
all other OTCs remained negative (Figure 4). CK5 remained
restricted to the basal layer under all conditions (not shown).
Changes in cell adhesion
Desmosomal proteins. In control OTC, antibodies against the
desmosomal proteins desmoplakin (DP), plakoglobin, Dsg1,
and desmocollin (Dsc)1 produced an epidermis-like inter-
cellular staining pattern. Dsg3 reactivity was extended to all
layers and Dsc2 was reduced to the lowermost suprabasal
layers, as opposed to normal epidermis, where both proteins
are expressed in a gradient from the basal to the upper
spinous layers (Kurzen et al., 1999). In nicOTC, muscOTC,
and carbOTC, the staining pattern remained unchanged but
the staining intensity of all desmosomal antibodies was
slightly more intense than in control OTC. In atropOTC, the
first noticeable change as compared to control occurred on
day 5: there was a marked cytoplasmic staining for
plakoglobin (not shown), Dsg3, and Dsc2, whereas Dsg1
could be detected only in the uppermost layers, in part also in
the cytoplasm. On day 7, with the appearance of acantho-
lysis, all desmosomal proteins displayed a drastically reduced
staining intensity. Especially in the acantholytic cells, the
staining intensity did not surpass background levels. Only the
cells directly neighboring the acantholytic zone showed a
weak cytoplasmic staining. Dsc1 could not be detected. In
mecOTC, the changes on day 5, preceding the onset of
acantholysis, were not as marked as in atropOTC. From day
7, however, acantholysis was pronounced and the changes in
desmosomal protein expression could not be distinguished
from the atropOTC specimens. In the very thin, immature
epithelium of stryOTC on day 5, all antibodies displayed a
diffuse cytoplasmic staining. From day 7, the acantholytic
epithelium showed a weak cytoplasmic DP and Dsg3
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Figure 3. Epithelial thickness. The thickness of epidermal living layers
was assessed by measuring at three different representative parts of three
experiments. The obtained data were pooled. Mean and standard deviation
were determined using a Student’s t-test. Treatment with muscarine and
carbachol leads to a slight but significant (*Po0.05) increase in epithelial
thickness, whereas nicotine has a much more pronounced effect
(**Po0.0001). In contrast, treatment with atropine and strychnine
significantly reduce epidermal thickness. All other substances applied, in
particular mecamylamine, did not change epithelial thickness significantly.
www.jidonline.org 2461
H Kurzen et al.
Epidermal Cholinergic System In Vitro
staining, whereas all other desmosomal proteins could not be
detected. In hexOTC, curOTC, and bgtxOTC, there were no
significant differences compared to control OTC. In gpbOTC,
the distribution of all desmosomal proteins was markedly
altered, with cytoplasmic staining and a chaotic order
reflecting a disturbed keratinocyte synchronization (Figure 5,
Table 1). Performing quantitative real-time RT-PCR analysis,
we could demonstrate a reduction of Dsg3 mRNA (relative to
GAPDH mRNA) to 38% of control OTCs in stryOTCs on day
10 (not shown).
a b c d e
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Figure 4. Markers of terminal differentiation in OTC. In control OTC (day 10), (a) CK2e expression in the upper epidermal layers is slightly less intense than in
normal epidermis, whereas (f) CK10 and (k) filaggrin expression correspond to normal epidermis. In (b) nicOTC and (c) carbOTC, (b, c) Ck2e and (l, m) filaggrin
are strongly expressed in the granular and uppermost spinous layers indicating increased maturation and cornification of the epithelium. (g) Ck10 staining
pattern in nicOTC seems less compact than in (f) control and (h) carbOTC. Treatment of OTCs with a-bungarotoxin did not change (d) CK2e, (i) CK10,
or (n) filaggrin expression significantly compared to (a, f) control. In contrast, in the (e) mecOTC, CK2e remained completely negative at all times whereas
only a weak (j) CK10 and (o) filaggrin expression could be detected. Bar¼100 mm.
Table 1. Summary of expression patterns in fully developed OTCs (10 days in culture)
DP PG Dsg1 Dsg3 Dsc1 Ecad b-Cat ZO-1 a6-Int b1-Int Lam Fil CK2e CK5 CK10 CK6/16 CK19
Epidermis ++ ++ ++ ++ + + ND + + + + + ++ + ++  
Control + ++ ++ + + + ND + + + + + (+) + + + 
Nicotine + ++ + ++ + + + + + + + + + + + + 
Muscarine + ++ + + + + + ++ + + + + + + + + 
Carbachol ++ ++ ++ ++ ++ ++ ++ ++ + + + + + + + + 
Atropine (+)cp  (+) (+)cp   (+) (+)cp + +  (+)  (+) (+) ++ 
Mecamylamine (+)cp  (+) (+)cp   (+) (+)cp + +  (+) (+) (+) (+) + 
Strychnine (+)   (+)   (+)  + +  (+)  (+)  + 
d-Tubocurarin + ++ + +  + + + + + + +  + + + 
Hexamethonium + ++ + +  + + + + (+) + + + + + + 
a-Bungarotoxin + ++ (+) + (+) + + + + + + + + + + + 
Glycopyrrolate + ++ + + +cp + + (+)cp + + + +  + + + 
CK, cytokeratin; DP, desmoplakin; Dsc, desmocollin; Dsg, desmoglein; OTC, organotypic coculture; PG, plakoglobin.
Legend: +, positive; ++, strong reactivity; (+), weak reactivity; , negative; cp, cytoplasmic staining; ND, not done.
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Adherens junctions. In normal epidermis and control OTC,
nicOTC, muscOTC, and carbOTC, E-cadherin and b-catenin
antibodies brightly decorated cell membranes of all living
layers. In mecOTC and atropOTC, the staining intensity was
slightly reduced on day 5. With the appearance of
acantholysis on day 7, E-cadherin and b-catenin turned
almost completely negative. In stryOTC, adherens junction
protein antibodies produced a diffuse cytoplasmic staining
hardly above background levels. In gpbOTC, the E-cadherin
and b-catenin antibodies’ staining intensity was comparable
to control OTC; however, the disturbed epithelial architec-
ture became clearly visible and many cells showed a
cytoplasmic staining (Figure 6, Table 1). Performing quanti-
tative real-time RT-PCR analysis, E-cadherin mRNA could not
be detected in stryOTCs (not shown).
Tight junctions. The tight junction protein ZO-1 (TJP1) and
claudin 4 could be detected in cell membranes of the upper
spinous and granular layer of normal epidermis and fully
developed control OTC. In immature OTC of day 5, ZO-1
and claudin 4 stainings were often weak and cytoplasmic.
The most prominent and extended ZO-1 staining, reaching
down to the lower suprabasal layers, was obtained in
carbOTC, whereas in nicOTC and muscOTC, no significant
changes were noted as compared to control OTC. In the same
specimens, claudin 4 remained restricted to the upper
spinous and the granular layer (Figure 7f–h). In mecOTC,
atropOTC, and stryOTC, ZO-1 and claudin 4 staining
intensity was strikingly reduced, being restricted to the
cytoplasm of the cells in close proximity of the acantholytic
zones. Like for the desmosomal proteins, gpbOTC produced
a chaotic, mostly cytoplasmic ZO-1 staining (Figure 7e) and
led to claudin 4 decorating areas of premature cornification
(Figure 7j). In all other OTCs, there was no significant
difference as compared to control (not shown).
Basement membrane components
In control OTC, a6- and b1-integrin and laminin appeared on
day 5 in the basal cells, from day 7 onwards, there was an
epidermis-like linear deposition, indicating the formation of
an intact basement membrane. In the nicOTC, muscOTC,
and carbOTC, all three proteins were deposited in a similar
way. In addition, the b1-integrin antibody decorated the
basal and spinous layers of control OTC, nicOTC and
carbOTC, and muscOTC. In atropOTC, mecOTC, and
stryOTC, a6- and b1-integrin could be detected along the
basement membrane, whereas laminin remained negative.
Except for a slightly reduced staining intensity of the b1-
integrin antibody in hexOTC, there were no significant
changes as compared to control under all other conditions
(Figure 8).
Induction of apoptosis in OTCs via the intrinsic pathway
After having observed prominent acantholysis in the mecOTC,
atropOTC, and stryOTC, we sought to determine whether
apoptosis is induced under these conditions. Performing the
TUNEL assay, we found significantly increased fluorescence
signal intensity and signal distribution in the stratum spinosum
and especially in the acantholytic cells of the mecOTC,
atropOTC, and stryOTC from day 7 onwards, whereas under
all other conditions, especially in mecOTC, atropOTC, and
stryOTC examined on day 5, that is, before the onset of
acantholysis, no differences could be observed as compared to
control OTC. In the same specimens, an antiserum against
activated caspase 3 showed prominent staining of the
acantholytic cells (Figure 9), whereas under all other conditions,
no staining could be observed. Using antibodies against caspase
8, Bax, and CD95, we did not observe any significant staining
as compared to sections obtained from patients with pemphigus
vulgaris or basal cell carcinomas, which both showed
prominent staining of these proapoptotic proteins (not shown).
Premature lipid deposition in ‘‘acantholytic’’ OTCs
A modified Nile red staining was used in order to assess the
lipid composition of the stratum corneum and the degree of
maturation reached by the organotypic cultures. Normal
human skin and diseased skin with perturbed skin barrier
(psoriasis, eczema) was used in comparison.
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Figure 5. Distribution of desmosomal cadherins. Colocalization of Dsg3
(green) and Dsc2 (red) nuclear counterstain with 40,6-diamidine-20-phenyl-
indole dihydrochloride (blue). In normal epidermis, (a) both proteins are
expressed in all layers, with a predominance in the basal and spinous layers.
In OTCs, maturation goes along with a change of Dsc2 distribution, retracting
from the upper layers, whereas Dsg3 expression remains unchanged
(b) control after 5 days, (c) after 10 days. Atropine leads to a redistribution of
desmosomal proteins, (d) producing a prominent cytoplasmic staining after
5 days and (e, arrows) prominent acantholysis after 10 days with significantly
reduced staining intensity of all Dsg3 and Dsc2. In contrast, muscarine
treatment (f, after 5 days) leads to a bright cell membrane staining, not
discernable from control OTCs. (g) Also mecamylamine significantly
alters Dsg3 and Dsc2 expression already on day 5, however, staining is
predominantly confined to the cell membrane and not the cytoplasm.
(h) After 10 days, mecamylamine treatment acantholysis is evident and
staining intensity of Dsg3 and Dsc2 is grossly reduced. (i) In contrast,
in nicOTCs, the distribution pattern corresponds to control. Bar¼ 100mm.
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Alkaline extension of the stratum corneum revealed
regular ‘‘mortar and brick’’ structure of the stratum corneum
of normal skin and untreated organotypic cultures.
The first signs of cornification and extracellular lipid
deposition were seen 5 days after air lifting; after 10 days, a
fully developed stratum corneum displayed intercellular
lipid deposition with focal accumulations of lipid droplets.
In psoriatic skin, the regular ‘‘brick and mortar’’ structure was
severely disturbed, leading to a diffuse non-specific staining.
The atropOTC, mecOTC, and stryOTC displayed signs
of premature, intracellular lipid production, already in the
lowest suprabasal layers, most notably also in the acantho-
lytic cells. In nicOTC, carbOTC, or muscOTC, no premature
lipid production was noted, instead, lipids were intensely
produced in the stratum corneum. Under all other
conditions, no changes were noted as compared to control
(Figure 10).
Proliferative activity in OTCs
The proliferative activity of the different OTCs was assessed
using an antibody against Ki-67 (Mib-1). In normal epidermis,
about 10% of the nuclei in the basal layer are reactive. In
immature control OTCs and agonist-treated OTC, there was a
slight increase to 10–20%. In the antagonist-treated OTCs up
to day 5, we did not detect any significant decrease in the
Ki-67 ratio. However, in the mecOTC, atropOTC, and
stryOTC, beginning with the onset of acantholysis on day 7,
only single Mib-1-positive nuclei could be detected (Figure
11). All other OTCs showed no significant changes compared
to control OTC (not shown).
a b c d e f
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Figure 6. Distribution of adherens junction proteins. In (a, g) control OTC adherens junction proteins examined, namely (a) E-cadherin and (g) b-catenin
are broadly expressed in all living epidermal layers. Treatment with (b, h) nicotine or (c, i) carbachol leads to a slightly increased signal intensity for
(b, c) E-cadherin and (h, i) b-catenin. In contrast, with the appearance of acantholysis on day 7, after treatment with (d, j) mecamylamine and (e, k) atropine,
the staining intensity for all adherens junction proteins was markedly reduced. Especially in the acantholytic cells, (d, j, e, k) E-cadherin and b-catenin
turned completely negative. In gpbOTC, (f, l) the E-cadherin and b-catenin antibodies’ staining intensity was comparable to control OTC, however, the
disturbed epithelial architecture become clearly visible (f, l, arrows) and many cells showed a cytoplasmic staining. Bar¼100 mm.
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Figure 7. Distribution of tight junction proteins. Fully developed OTC treated with (b, g) carbachol, (c, h) nicotine, (d, i) mecamylamine, and (e, j)
glycopyrrolate. ZO-1 could be detected in cell membranes of the upper spinous and granular layer of fully developed (a) control OTC whereas (f) Claudin 4
remained restricted to the granular cell layer. The most prominent and extended ZO-1 staining reaching down to the lower suprabasal layers was obtained
in (b) carbOTC and (c) nicOTC whereas (g, h) Claudin 4 did not show a significant change. In (d, i) mecOTC, ZO-1 and Claudin 4 staining intensity was
significantly reduced, being restricted to the cytoplasm of the cells in close proximity of the acantholytic zones. Like for the desmosomal proteins, glycopyrrolate
treatment produced a chaotic, in part (e) cytoplasmic ZO-1 – and (j) Claudin 4 staining. Bar¼100 mM.
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DISCUSSION
After previously having provided a concise phenotypical
mapping of AChR present in human skin, our goal was to
obtain functional data of AChR stimulation and inhibition in
living three-dimensional skin equivalents. The technique of
OTCs has been developed and studied in detail by one of us
(N.M-S.) and is hence suited to test the impact of cholinergic
compounds on various aspects of epidermal physiology. Our
first question was whether ACh is needed for epidermal
development and survival, at all. Blocking of all AChR,
present in control OTC in an epidermis-like distribution
(Figure 2), specifically inhibited the formation of an intact
epithelium, leaving behind a monolayer of viable, non-
differentiated cells, without exerting cytotoxic effects. This
observation is well in line with potent antiproliferative effects
observed for several nAChR or mAChR blocking compounds
in different cell systems (LeSage et al., 1999; Arredondo et al.,
2003). In contrast, blocking of the a7nAChR has been
suggested to enhance proliferative activity in mouse kerati-
nocytes cultured in monolayers (Arredondo et al., 2002), a
finding we could not substantiate in our system, most
probably because a7nAChR were produced only in the last
stages of epidermal development, that is, after day 10, along
with the formation of a granular layer (Figure 2b). The
epithelium formed in the presence of 1 mM strychnine was
only two to four cell layers thick without any signs of terminal
differentiation. There was a weak expression of CK19, also
found in simple epithelia, underlining the lack of observed
maturation (Kurzen et al., 1999). As strychnine does also
inhibit glycine receptors, we wanted to rule out the possibility
that the observed effects were mediated by these ligand-gated
chloride channels. Addition of equimolar concentrations of
glycine to the stryOTC did not rescue the observed phenotype
(not shown). We therefore concluded that the observed
strychnine effects were predominantly mediated by inhibition
of a9nAChR and consequently, a9nAChR are crucially
involved in the development of a normal, differentiated
epidermis. Quantitative analysis revealed a highly significant
upregulation of a9nAChR mRNA in the course of epithelial
maturation in control OTCs underlining its importance for a
normal epidermal development.
As second most important finding, we observed prominent
acantholysis after treatment with atropine, mecamylamine,
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Figure 8. Changes in cell–substrate adhesion. In (a, d, g) control OTC,
(a) beta-1 and (d) alpha-6 – integrin are produced by basal and suprabasal
cells indicating a hyperproliferative state with reduced epithelial polarity,
(g) whereas laminin remains restricted to the basal cells. (b, e, h) In
nicotine-treated OTCs, polarity is improved as indicated by retraction of b1
and a6 to the basal cells. Treatment with mecamylamine does not influence
(c) b1 and (f) a6 integrin expression. Both proteins are detectable in a linear
pattern below the acantholytic zone. (i) In contrast, laminin signal intensity
does not surpass background level. Bar¼ 100mm.
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Figure 9. Detection of apoptosis. In order to detect apoptosis, the TUNEL
reaction was performed in all OTCs. Blue counterstaining of nuclei with 40,6-
diamidine-20-phenylindole dihydrochloride, TUNEL signal green. Compared
to (a) control, (b) nicotine does not increase signal intensity in the nuclei in
any of the layers. In contrast, even in the granular layer signal intensity seems
to be reduced. In (c) mecOTC and (d) atropOTC, there is a strong increase in
signal intensity in all epidermal layers. Activated caspase 3 is a late marker of
apoptosis. (e–h) Double labeling of activated caspase 3 (red), DP (green), and
40,6-diamidine-20-phenylindole dihydrochloride (blue). While in (e) control
OTCs, DP displays a regular labeling and caspase 3 is not detectable, in
(f) atropOTC, (g) mecOTC, and (h) stryOTC, there is a prominent activated
caspase 3 signal in the acantholytic cells and a weaker signal in the
surrounding cells. Note absence of DP in the acantholytic cells (arrows).
Bar¼100 mm.
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and strychnine. As AChR, especially the a9nAChR, have been
suggested to play a role in the pathogenesis of the
autoimmune blistering disease pemphigus vulgaris, we
wanted to know whether the acantholysis observed in our
model corresponds to pemphigus acantholysis or rather other
(congenital) acantholytic diseases like Darier’s disease.
Acantholysis started on day 7 after airlifting. On day 5,
acantholysis was not observed but adhesion molecules began
to localize to the cytoplasm. Inhibition of both the ligand-
gated ion channels (nAChR) by mecamylamine and blockage
of G-protein-coupled receptors (mAChR) lead to similar
results, which is quite a stunning observation. As both
receptor systems are involved in the regulation of intra-
cellular calcium ions (Zia et al., 2000; van Koppen and
Kaiser, 2003), we suspected that calcium-dependent adhe-
sion molecules might be involved in the observed acantho-
lysis. We could confirm this hypothesis by examination of
desmosomal and classical cadherins, both of which were
dramatically reduced in the IF analysis in the acantholytic
OTC. Using quantitative real-time RT-PCR analysis, we could
demonstrate that in the strychnine-treated OTCs that were
chosen as an example of ‘‘acantholytic’’ OTCs, Dsg3 and
E-cadherin were significantly downregulated on the mRNA
level.
In addition, also desmosomal and adherens junction
plaque proteins DP, plakoglobin (g-catenin), b-catenin, and
even tight junction proteins like ZO-1 were found signifi-
cantly reduced in IF. Our findings of a ‘‘global’’ down-
regulation of virtually all cell–cell adhesion molecules
examined, surpasses the pattern found for pemphigus vulgaris
and Darier’s disease where single adhesion molecules like
Dsg3 and plakoglobin for pemphigus vulgaris or DP for
Darier’s disease have been found altered (Setoyama et al.,
1991; Hashimoto et al., 1995; Aoyama and Kitajima, 1999;
Hakuno et al., 2000; Dhitavat et al., 2003). Our results are
well in line with previous studies showing phosphorylation
(and thus inactivation) of Dsg3, E-cadherin, and b-catenin by
atropine in a squamous cell carcinoma cell line and
upregulation of Dsg1 and Dsg3 in keratinocyte monolayers
by carbachol treatment. Interestingly, mecamylamine did not
lead to altered phosphorylation of these molecules in the
same system indicating the involvement of different signaling
cascades (Nguyen et al., 2003).
Using our model, for the first time, we provide evidence
that inhibition of AChR can lead to acantholysis in a three-
dimensional in vitro epidermis equivalent which closely
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Figure 10. Influence on lipid production. Using Nile red staining with
alkaline extension of the stratum corneum, a regular ‘‘mortar and brick’’
structure of the stratum corneum of (a) normal skin and (b) untreated
organotypic cultures (c) in contrast to psoriasis is revealed. Lipids stain in
bright yellow. Note that in normal epidermis and control OTC, there are only
single cells showing bright yellow signals in the living layers of the epidermis,
whereas in (b) psoriasis as well as in (g) mecOTC, (h) atropOTC, and
(i) stryOTC already in the lowest suprabasal layers, many keratinocytes
display a brightly yellow cytoplasm indicating intracellular accumulation
of lipids. In (d) nicOTC, (e) carbOTC, or (f) muscOTC, no premature lipid
production was noted, instead, lipids were intensely produced in the stratum
corneum. Bar¼ 100mm.
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Figure 11. Influence on keratinocyte proliferation. The proliferation marker Ki-67 is detected in 10–20% of nuclei in basal layer of the control OTCs on
(a) day 5 whereas on (e) day 10 only single signal clusters could be detected. Neither (b) nicOTC, (c) muscOTC, nor (d) mecOTC show significantly altered
signal ratios on day 5. (carbOTC, f) In contrast, on day 10, proliferative activity is still present in the agonist-treated OTCs. (g) In a-bungarotoxin-treated
OTCs, the signal frequency is comparable to control, (mecOTC, h) whereas in the acantholytic OTCs most specimens remained completely negative.
Bar¼100 mm.
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resembles the in vivo situation. In contrast to pemphigus
vulgaris, we did not find the typical ‘‘tombstone’’- pattern of
remaining basal keratinocytes, instead, single basal cells
remained attached to the dermis equivalent. This observation
can be explained by the rather poor stability of OTCs
employing collagen hydrogels as dermal equivalents. In
particular, formation of an intact basement membrane is
limited, despite the presence of basement membrane
components (Stark et al., 2004b). In addition, we observed
a reduction of laminin in acantholytic OTCs, adding a further
explanation to the observed phenotype.
Biochemical induction of acantholysis has been demon-
strated in skin explant cultures by millimolar concentrations
of several substances, among which calcium channel
antagonists like nifedipine and angiotensin-converting en-
zyme inhibitors like enalapril (Brenner et al., 1999; Lo
Schiavo et al., 1999). Obviously, nifedipine interferes with
intracellular calcium homeostasis in keratinocytes thus
pointing the way to a common possible mechanism together
with the anticholinergic, calcium-reducing effects observed
in our system. Our data provide further basis for the clinical
use of cholinergic agonists like nicotine or carbachol as
antiacantholytic compounds either locally or systemically. As
the extraneuronal cholinergic system is also involved in the
regulation of inflammatory reactions and cholinergic agonists
have shown potent anti-inflammatory capacity, these drugs
might be valuable adjuncts to the treatment of pemphigus
vulgaris (Grando, 2000; Nguyen et al., 2000a, b, 2004a;
Grando et al., 2001).
Like in pemphigus vulgaris, acantholysis in our system was
associated with apoptosis, as evidenced by the TUNEL
reaction and activated caspase 3. Although the TUNEL
reaction showed prominent signals in all layers of the
respective epithelia, activated caspase 3 was restricted to
the acantholytic cells, thus paralleling the absence of
intercellular adhesion molecules. In contrast to pemphigus
vulgaris, ‘‘perilesional’’ cells did not show caspase 3 activity.
Inactivation of adherens junction has been shown to lead to
apoptosis in other epithelia and also a very attractive
explanation for the apoptogenic mechanism observed in
our OTC (Hermiston and Gordon, 1995). Interestingly,
neither caspase 8, CD95 nor Bax were upregulated in the
acantholytic OTCs, well in line with an intrinsic apoptotic
pathway, which is in contrast with the extrinsic pathway in
pemphigus vulgaris (Reed, 2000; Wang et al., 2004). We
therefore conclude that in our acantholysis model, neither
acantholysis nor apoptosis are induced by the same
mechanism as in pemphigus vulgaris. Further studies have
to show, whether this might be related to our rather broad
pharmacological approach or to the lack of specific signaling
pathways.
Apoptosis has been shown to be induced by the loss of cell
substrate adhesion, a process is also termed anoikis (Frisch
and Francis, 1994). With the exception of the slightly reduced
basement membrane component laminin, the expression of
the cell–matrix adhesion molecules a6- and b1-integrin was
intact in the acantholytic OTC, arguing against a major role of
cell–substrate adhesion in apoptosis induction in our system.
Interestingly, it has been shown, that activation of mAChR
can prevent caspase 2/3 activation by phosphoinositide
3-kinase- and mitogen-activated protein kinase/extracellular
signal-regulated kinase-independent pathways. It thus seems
plausible that inhibition of mAChR by atropine can induce or
promote caspase activation leading to apoptotic cell death, as
observed in our system (Leloup et al., 2000). Other pathways
of apoptosis regulation have been described for nAChR in
cortical thymus epithelial cell lines (Rinner et al., 1994) and
in mesothelioma cells, which may act via induction of NF-kB
complexes and phosphorylation of Bad at serine (112). In this
system, curare leads to apoptosis via p21 (waf-1)-dependent
but p53-independent G(0)–G(1) arrest (Trombino et al.,
2004). On the other hand, 24 hour exposure of human
dermal fibroblast (HDF) to 10mM nicotine causes a 1.7- to
2-fold increase of the apoptosis regulators Bcl-2 and caspase
3, an effect suggested to be mediated by a3* nAChR
(Arredondo et al., 2003) and may be explained by calcium
overload after overstimulation of cholinergic receptors, a
mechanism observed in neural cells (Szabadkai and Rizzuto,
2004). In the epidermis, apoptosis has been proposed to be a
central mechanism in the transition of differentiating kerati-
nocytes from the stratum granulosum to the stratum corneum,
a process termed ‘‘apoptotic secretion’’ and mediated by
cholinergic receptors, most probably the a7-nAChR, present
in the stratum granulosum. In this case, CD95 and Bax
seem to be centrally involved (Arredondo et al., 2003). In
our system, we were not able to corroborate this finding,
which however, may be due to the duration of the organo-
typical culture and hence the degree of cornification. Most
notably, neither nicotine- nor a-bungarotoxin-treated cultures
displayed increased apoptotic activity, CD95, or Bax
upregulation.
Another important aspect in our study was the impact of
the cholinergic system on epidermal differentiation and
barrier formation. Starting with a thorough examination and
quantification of the obtained epithelial thickness, we could
show that in our system, the use of both mecamylamine and
atropine led to a significantly delayed or impaired epidermal
maturation as evidenced by reduced expression of typical
markers of terminal differentiation like CK2e, CK10, filaggrin,
Dsc1, and ZO-1. In contrast, we found a significantly
increased epithelial thickness after treatment with cholinergic
agonists. Nicotine produced the most impressive increase in
epithelial thickness, whereas the effects observed for mus-
carine and carbachol were less pronounced. An increased
polarity could be demonstrated for all cholinergic agonists. In
hyperproliferative skin diseases, such as skin cancer or
psoriasis vulgaris, and in normal keratinocytes forced into
more frequent cell cycles, the polarized expression of
integrins is lost, and a5b1 integrins becomes constitutively
expressed on the plasma membrane (De Luca et al., 1994).
Control OTCs have been shown in several studies to be in a
hyperproliferative or activated state, as indicated by the
expression of CK 6/16. Likewise, in our control OTCs, a6-
and b1-integrins were located in the basal and lower
suprabasal layers. With increasing maturation, both integrins
become increasingly restricted to the basal keratinocytes,
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a phenomenon we could observe in OTCs treated with either
cholinergic agonist. The restriction of integrin expression as
well as keratinocyte proliferation to the basal layer upon
stimulation with cholinergic agonists underlined the restored
tissue polarity (Stark et al., 2004b).
Using antibodies against Ki-67, we could not demonstrate
an acceleration of epidermal differentiation, for example, on
day 5 or 7 as compared to control; however, OTCs treated
with cholinergic antagonists, displayed a significantly re-
duced proliferative activity.
It is well established, that keratinocytes grow better in
culture if choline is present and hence virtually all culture
media for keratinocytes contain B104 to 105 M choline-
chloride. Thus, our results support this view of cholinergic
agonists acting as a sort of trophic factor for keratinocyte
growth and differentiation (Gordon et al., 1988). The lipid
content of the stratum corneum did not differ significantly
between control and OTCs treated with cholinergic agonists.
However, an interesting finding was the premature intracel-
lular production of lipids already in the lower suprabasal
layers, after treatment with cholinergic antagonists. Prema-
ture intracellular lipid production is a marker of abnormal
keratinization and/or a hyperproliferative effect. In addition,
it has been described after treatment of human skin with
different agents such as retinoids, SDS, dithranol, UVB-
irradiation, peroxisome proliferator-activated receptor acti-
vators and others (Kanerva, 1990; Feldman et al., 1991;
Schmuth et al., 2004). This finding has been interpreted as
stress or defense reaction to restore epidermal barrier integrity
(Grubauer et al., 1989; Holleran et al., 1991; Corsini et al.,
2003). Interestingly, in rat adipocytes, a direct link between
nAChR and lipid production has been demonstrated (Liu
et al., 2004). The inflammatory skin diseases, psoriasis, and
atopic dermatitis also show impaired barrier function, but the
underlying mechanisms remain under investigation. Recent
studies in genetically engineered mice have suggested an
unexpected role for tight junctions in epidermal barrier
function (Madison, 2003). This is well in line with our
observation of a significantly extended distribution of the
tight junction protein ZO-1 in OTCs treated with cholinergic
agonists. An extension of tight junction to spinous layers can
be interpreted as a tightening of the epidermal barrier.
We used pharmacological cholinergic compounds to
selectively stimulate or inhibit AChR, thus mimicking the
biological process in which ACh and choline are the natural
ligands and AChRs are either functional or not. The
traditional view of cholinergic compounds has changed
considerably in recent years, with the use of more refined
electrophysiological and molecular biology methods.
According to recent studies in different biological systems,
mecamylamine, d-tubocurarine, and hexamethonium
non-competitively block a3*- and a7-nAChR, with mecamyl-
amine being the strongest inhibitor at the a3*-nAChR.
D-tubocurarine displays greater affinity to the a3b4-nAChR
than hexamethonium, whereas both show corresponding
affinities at the a3b2-nAChR. At the concentration of 1 mM
used in our study, about 50% of a7-nAChRs are blocked
by mecamylamine. Mecamylamine is proposed to have
inhibiting activity at the a9-nAChR, a quantification of this
activity has – to our knowledge – not been published. The
lack of acantholytic activity of hexamethonium and D-
tubocurarine may primarily be explained by their insufficient
inhibitory action at the a9-nAChR, whereas for a-bungar-
otoxin the most likely explanation is due to its Mw of
B8 kDa, insufficient diffusion through the collagen gel (Xiao
et al., 1998; Verbitsky et al., 2000). Atropine has traditionally
been viewed as antimuscarinergic agent, however, recent
studies have provided a rather pancholinergic inhibitory
action in the rank order mAChR 4a9-4a7-4a3-nAChR
(Zwart and Vijverberg, 1997). In contrast to all other AChR,
neither nicotine nor muscarine act as agonists at the a9nAChR,
whereas ACh and choline are endogenous agonists and
carbachol is a synthetic partial agonist (Verbitsky et al., 2000).
Adding the pharmacological profile for the cholinergic
substances used, to the distribution of the AChR in the
epidermis and OTC of different developmental stages, it is
most likely that inhibition of either a3*- or a9nAChR, which
are both expressed in the basal and lower suprabasal layers,
is necessary to induce acantholysis. In addition, inhibition of
at least the stimulatory M3 AChR, possibly also the M5 AChR,
which are both found in the basal layer, seems to produce
similar effects. In contrast, predominant inhibition of the M1
AChR by glycopyrrolate did not lead to acantholysis but
disturbed epithelial architecture in the upper epidermal
layers, thus interfering with barrier formation. These conclu-
sions are supported by recent findings using knockout and
gene-silencing approaches (Nguyen et al., 2004b).
In conclusion, we could demonstrate an essential role for
ACh in epidermal physiology. Our functional data provide
insight into cholinergic control mechanisms of keratinocyte
adhesion, differentiation, and barrier formation, the sum of
which is likely to be involved in several skin diseases. The
exact mechanisms, especially the role of the different AChR
subunits, remain to be determined.
MATERIALS AND METHODS
Tissues
Normal human adult skin from the margins of routine surgical
procedures and skin biopsies from patients with psoriasis, pemphi-
gus vulgaris, and basal cell carcinoma were obtained after informed
consent according to the Declaration of Helsinki Principles and
approved by the local ethical committee. Samples were frozen in
isopentane cooled in liquid nitrogen immediately after removal and
stored at 801C. Fresh samples were used to isolate normal
epidermal keratinocytes and HDFs.
Cell culture
HDFs and normal epidermal keratinocytes were isolated from skin
specimens as described (Stark et al., 1999). HDFs were grown in
DMEM (Bio Whittacker, Heidelberg, Germany) supplemented with
10% fetal calf serum. For OTCs, either senescent HDF of passages
410 or mitomycin C (8mg/ml; Sigma, Steinheim, Germany)-treated
HDF or X-irradiated (70 Gy) HDF were used. Normal epidermal
keratinocytes were grown on feeder HDF in FAD medium (DMEM:
Ham’s F12/3:1) with 100 U/ml penicillin, 100 mg/ml streptomycin,
and supplemented with 5% fetal calf serum, 5 mg/ml insulin, 1 ng/ml
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recombinant epidermal growth factor, 1010 M cholera toxin, 104 M
adenine, and 0.4 mg/ml hydrocortisone (Sigma) as described (Stark
et al., 2004a).
OTCs
Lyophilized collagen type I was resolubilized at 4 mg/ml in 0.1%
acetic acid and kept at 41C. Collagen from different sources was
used in parallel experiments without any obvious differences
detectable. Rat tail collagen was either hand-isolated or bought
from Sigma, calf skin collagen I was obtained from IBFB (Leipzig,
Germany). The ice-cold collagen solution was mixed with Hank’s
salt with phenol red (Seromed Biochrom KG, Berlin, Germany) and
adjusted to pH 7.4. The HDFs were resuspended in fetal calf serum
and added to the gel to give 105 cells/ml in the collagen gel under
cautious stirring. A 2.5 ml of the collagen/HDF solution was poured
onto filter inserts (3 mm pore size, BD Falcon, Becton Dickinson,
Heidelberg, Germany) of a 6-fold deep well plate (BioCoat, Becton-
Dickinson, Heidelberg, Germany). After gelation, glass rings were
mounted on the gels in order to define the area of epithelial cell
growth. The gels were equilibrated by complete immersion in
culture medium for 24–48 hours. Thereafter, the normal epidermal
keratinocytes were plated inside the glass rings at a density of
106 cells/well. After 2 days, the glass rings were carefully removed
and the medium level was lowered to the lower part of the gel, thus
raising the keratinocytes to the air–liquid interface and restricting
nourishment to diffusion from below. The air lift procedure is
defined as day 0 of OTC. OTCs were grown in FAD medium with
10% fetal calf serum and 50 mM ascorbic acid. Medium was changed
every 2–3 days. Alternatively, OTC were grown under serum-free
conditions from day 0 as described (Stark et al., 1999) using
keratinocyte-defined medium (Promocell, Heidelberg, Germany)
without pituitary extract containing 5 mg insulin/ml, 0.5 mg
hydrocortisone/ml, 0.1 ng/ml human recombinant epidermal
growth factor, 20 mg/ml transferrin (Promocell), 0.1% highly purified
BSA (Vitromex, Selters, Germany), 50 mg/ml L-ascorbic acid, adjusted
to 1.3 mM Ca2þ . At the end of the experiment, the epidermal-
collagen specimens were snap frozen in liquid nitrogen and stored
at 801C.
In a single experiment, OTCs of one condition were always
performed twice. All cell culture experiments were repeated at least
twice. Cholinergic compounds were added to the OTCs on the day
of the air-lift in concentrations ranging from 10 mM to 1 mM. We used
nicotine as stimulus for the nAChR, muscarine as stimulus mAChR,
and carbachol (carbamoylcholine chloride) as pancholinergic
stimulus. Mecamylamine, hexamethonium, and d-tubocurarine
were used to non-competitively block nAChR, a-bungarotoxin was
used to reversibly block the homooligomeric nAChR, strychnine was
used to block a9nAChR. mAChR were blocked by atropine and
glycopyrrolate (which has 100 times higher affinity to m1 than to
m2 and m3). All cholinergic substances were from Sigma.
Determination of epithelial thickness
The epithelial thickness obtained using the described culture
conditions was determined by measuring the thickness of the
malpighian layer at two representative points of each specimen, so
that for each condition, at least six different values were obtained.
Statistical analysis was performed using Student’s t-test (available on
www.statpages.net).
LDH release assay
Cell death leads to release of cytoplasmic proteins into the culture
supernatant. The determination of LDH is a well-established marker
of cytotoxic effects in cell culturing (Weyermann et al., 2005). We
used the cytotoxicity detection kit (Roche, Mannheim, Germany)
according to the manufacturer’s instructions and determined LDH
concentration in the culture supernatant at different time points. As
positive control, a corresponding number of keratinocytes of were
lysed using 1% Triton X-100.
IF staining
For IF analysis, 5 mm cryostat sections of human scalp skin were
either used air dried and unfixed or fixed either in ice-cold acetone.
IF reactions were performed at least three times on different
specimens according to standard procedures (Kurzen et al., 2004).
After blocking with 5% non-fat dry milk and 1% BSA in Tris-buffered
saline, the primary antibodies were applied to the specimens for
1 hour at room temperature or for 12 hours at 41C. The following
secondary antibodies were applied for 1 hour at room temperature:
Cy-2 and Cy-3 coupled preabsorbed goat anti-mouse, -rabbit and
-guinea-pig antisera and a Cy-3 coupled rabbit anti-goat antiserum,
all obtained from Dianova (Hamburg, Germany). In order to
enhance the signal intensity, biotin-coupled secondary antibodies
were used. Antibody binding was visualized with Cy-2- or Cy-3-
coupled streptavidin (Dianova). Negative controls were performed
by replacing the primary antibody with phosphate-buffered saline or
an irrelevant, species-matched antibody. Washes (3 10 minutes) in
phosphate-buffered saline or Tris-buffered saline and Tween 20 were
performed after each step. The staining was observed and visualized
with a Leitz DMRB IF microscope. Antibodies used in the study are
listed in Table 2.
Nile red staining
In order to better discern stratum corneum lipids, alkaline
expansion was performed for 10 minutes using half-strength Sor-
ensen–Walbum buffer (0.1 M glycine, 0.1 M NaCl, and 0.1 M NaOH)
pH 10 or pH 12.5 as described (Talreja et al., 2001) and
gently rinsed with water. A Nile red stock solution containing
0.05% (wt/vol) Nile red in acetone was stored at 41C. Before
staining, the stock was diluted to 2.5 mg/ml with 75:25 (vol/vol)
glycerol:water (Fowler and Greenspan, 1985). A drop of the
glycerol–dye solution was applied to each section and immediately
covered with a coverslip. Nile red fluorescence was captured with a
Leitz microscope equipped with a fluorescein filter (450–490 nm
excitation filter).
TUNEL assay
In order to detect apoptotic cells, we used the in situ cell death
detection kit according to the manufacturer’s (Roche) description. In
brief, 5 mm thick frozen specimens were cut and fixed in 4%
paraformaldehyde. After rinsing in phosphate-buffered saline,
sections were permeabilized for 2 minutes. The TUNEL
reaction mix was added to the sections and incubated for 60 minutes
at 371C. After thorough washing, nuclei were counterstained
with 40,6-diamidine-20-phenylindole dihydrochloride (10 minutes at
room temperature) washed again and mounted with fluoromount
(Dako, Denmark). Positive control sections were pretreated with
DNAse I.
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RNA isolation and cDNA synthesis
For RNA isolation, the epithelial sheets were separated from the
collagen matrix and the RNA was isolated using RNeasy Mini kit
(Qiagen, Hilden, Germany) according to the recommendations of
the manufacturer. Total RNA was treated with 2 U RNase free DNase
(Ambion, Austin, TX) and used for RT with SuperscriptTM II reverse
transcriptase (Invitrogen, Karlsruhe, Germany) using oligo dT primers
according to the recommendations of the manufacturer. The
obtained cDNA was diluted 1:10 with DDH2O and 1 ml was used
for PCR reaction.
Real-time RT-PCR analysis
Real-time PCR analysis was performed using Assay-on-Demands
TaqMans assays together with TaqMans PCR master mix (all from
Applied Biosystems, Darmstadt, Germany) using standard condi-
tions. The following assays have been used: for a9nAChR (CHRNA9)
Hs00214034_m1, for desmoglein 3 –Hs00170075_m1, for E-cadhe-
rin Hs00170423_m1. As internal control, an assay for human GAPDH
was used together with TaqMans PCR master mix (Applied Biosystems).
Primers for GAPDH were: forward – F848 50-CATCCATGACAA
CTTTGGTATCGT; reverse – R848 50-CAGTCTTCTGGGTGGCAG
TGA. The probe for GAPDH was Pr849 FAM-AAGGACTCATGAC
CACAGTCCATGCC-BHQ1. Probe and primers were produced by
MWG-Biotech (Ebersberg, Germany). The experiments were
performed on ABI PRISMs 7000 sequence detection system
(Applied Biosystems). The expression levels of analyzed genes were
normalized to GAPDH mRNA expression.
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